Paper4768898
Isolation and characterization of glucocerebrosidase from human placental tissue.
Pentchev PG and 4 others. J Biol Chem, 1973. Cited by 137 papers, by iCite.
Cite this record
ConductScience Library. Isolation and characterization of glucocerebrosidase from human placental tissue. Papers, record 4768898. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4768898
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glycoside Hydrolases | Major topic |
| Placenta | Major topic |
| Carbon Radioisotopes | |
| Cerebrosides | |
| Chromatography, Gel | |
| Chromatography, Ion Exchange | |
| Chromatography, Thin Layer | |
| Detergents | |
| Electrophoresis, Disc | |
| Female | |
| Glucose | |
| Glycosides | |
| Humans | |
| Hydrogen-Ion Concentration | |
| Isomerism | |
| Kinetics | |
| Macromolecular Substances | |
| Molecular Weight | |
| Pregnancy | |
| Structure-Activity Relationship | |
| Taurocholic Acid |
Source PubMed
Cited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 137 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33192552 | Trends in Glucocerebrosides Research: A Systematic Review. | Front Physiol | 2020 | https://conductscience.org/library/papers/33192552 | PubMed |
| 28502768 | Lysosomal enzyme replacement therapies: Historical development, clinical outcomes, and future perspectives. | Adv Drug Deliv Rev | 2017 | https://conductscience.org/library/papers/28502768 | PubMed |
| 28314976 | Enzyme replacement therapy and beyond-in memoriam Roscoe O. Brady, M.D. (1923-2016). | J Inherit Metab Dis | 2017 | https://conductscience.org/library/papers/28314976 | PubMed |
| 28207759 | Investigations on therapeutic glucocerebrosidases through paired detection with fluorescent activity-based probes. | PLoS One | 2017 | https://conductscience.org/library/papers/28207759 | PubMed |
| 27916601 | Gaucher disease: Progress and ongoing challenges. | Mol Genet Metab | 2017 | https://conductscience.org/library/papers/27916601 | PubMed |
| 21030589 | Benefits from unearthing "a biochemical Rosetta Stone". | J Biol Chem | 2010 | https://conductscience.org/library/papers/21030589 | PubMed |
| 19774208 | Review of the safety and efficacy of imiglucerase treatment of Gaucher disease. | Biologics | 2009 | https://conductscience.org/library/papers/19774208 | PubMed |
| 17080196 | Mutation of beta-glucosidase 2 causes glycolipid storage disease and impaired male fertility. | J Clin Invest | 2006 | https://conductscience.org/library/papers/17080196 | PubMed |
| 12803925 | Enzyme replacement therapy: conception, chaos and culmination. | Philos Trans R Soc Lond B Biol Sci | 2003 | https://conductscience.org/library/papers/12803925 | PubMed |
| 8729108 | Enzyme replacement and gene therapy for Gaucher's disease. | Lipids | 1996 | https://conductscience.org/library/papers/8729108 | PubMed |
| 8516282 | Gaucher disease as a paradigm of current issues regarding single gene mutations of humans. | Proc Natl Acad Sci U S A | 1993 | https://conductscience.org/library/papers/8516282 | PubMed |
| 8301642 | The glucocerebrosidase locus in Gaucher's disease: molecular analysis of a lysosomal enzyme. | J Med Genet | 1993 | https://conductscience.org/library/papers/8301642 | PubMed |
| 7967500 | Modifying exogenous glucocerebrosidase for effective replacement therapy in Gaucher disease. | J Inherit Metab Dis | 1994 | https://conductscience.org/library/papers/7967500 | PubMed |
| 7306020 | Studies in vivo of the tissue uptake, cellular distribution and catabolic turnover of exogenous glucocerebrosidase in rat. | Biochem J | 1981 | https://conductscience.org/library/papers/7306020 | PubMed |
| 7275564 | Niemann-Pick disease type B in an Irish family. | Ir J Med Sci | 1981 | https://conductscience.org/library/papers/7275564 | PubMed |
| 6881138 | Immunological and catalytic quantitation of splenic glucocerebrosidase from the three clinical forms of Gaucher disease. | Am J Hum Genet | 1983 | https://conductscience.org/library/papers/6881138 | PubMed |
| 6775530 | Gaucher disease. III. Substrate specificity of glucocerebrosidase and the use of nonlabeled natural substrates for the investigation of patients. | Am J Hum Genet | 1980 | https://conductscience.org/library/papers/6775530 | PubMed |
| 6517862 | Characterization of the phospholipid requirement of a rat liver beta-glucosidase. | Biochem J | 1984 | https://conductscience.org/library/papers/6517862 | PubMed |
| 6455062 | Assignment of the gene for acid beta-glucosidase to human chromosome 1. | Am J Hum Genet | 1981 | https://conductscience.org/library/papers/6455062 | PubMed |
| 6418635 | Complementation analysis in Gaucher disease using single cell microassay techniques. Evidence for a single "Gaucher gene". | Hum Genet | 1983 | https://conductscience.org/library/papers/6418635 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4768898
GET https://conductscience.org/api/papers/v1/4768898/cited_by?page=2